-
Reasons to Hope During the COVID-19 PandemicPatient advocates learned about COVID-19 and cancer in an AACR virtual forum.
by Kevin McLaughlin
-
Forward Look
Creating More Inclusive Clinical TrialsThe Clinical Treatment Act aims to include more Medicaid recipients.
by Jen Tota McGivney
-
Survivor Profile
An Unlikely PivotMedha Deoras-Sutliff's experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.
by Lindsey Konkel
-
Policy Matters
The E-Cigarette Regulatory LandscapeThe FDA is taking several steps to restrict and reduce e-cigarette use among youth.
by Carmine S. Leggett, PhD
-
Get Involved
Patients With PetsA helping hand for pet owners receiving cancer treatment.
by Jackie Oshiro
-
Learning Medicare’s ABCDsMedicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.
by Kate Yandell
-
A Missed ConversationDespite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
From the Editor-in-Chief
Measuring a Cancer Drug’s EffectivenessSurrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
by William G. Nelson, MD, PhD
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
-
In It for the Long HaulDoctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
